Back to Search Start Over

Adaptation of multidisciplinary meeting decisions in a medical oncology department during the COVID epidemic in a less affected region of France: a prospective analysis from Bordeaux University Hospital.

Authors :
Heraudet L
Domblides C
Daste A
Gross-Goupil M
Ravaud A
Source :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2020 Aug; Vol. 135, pp. 98-100. Date of Electronic Publication: 2020 Jun 17.
Publication Year :
2020

Abstract

Competing Interests: Conflict of interest statement Luc Heraudet : nothing declared. Charlotte Domblides: advisory board participation: Astra-Zeneca ; accommodations and Travel support: Pierre Fabre, Astra Zeneca, BMS, MSD, Pfizer; Honoraria: Astra Zeneca, MSD. Amaury Daste: advisory board participation for Merck GA, BMS; accommodations and travel support by Merck GA, BMS, Astra Zeneca. Baptiste Sionneau: honoraria by BMS and Ipsen, accommodations and travel support by Pfizer. Marine Gross-Goupil: advisory board participation for Pfizer, Merck GA, Novartis, Ipsen, Roche, Astra Zeneca, MSD, accommodations and travel support by Pfizer, Merck GA, Novartis, Ipsen, Roche, Astra Zeneca, MSD, honoraria MSD, BMS ,Ipsen. Alain Ravaud : non financial support by Pfizer and Merck GA, advisory board participation for Pfizer, Merck GA, Novartis, Ipsen, Roche, Astra Zeneca, MSD, accommodations and travel support by Pfizer, Merck GA, BMS, Novartis, Ipsen, Roche, Astra Zeneca, MSD.

Details

Language :
English
ISSN :
1879-0852
Volume :
135
Database :
MEDLINE
Journal :
European journal of cancer (Oxford, England : 1990)
Publication Type :
Editorial & Opinion
Accession number :
32559628
Full Text :
https://doi.org/10.1016/j.ejca.2020.04.039